CD8A and cancer: Especially, owing to the in-situ amplification in both PDT and PTT by mitochondria-targeting, FEPT can effectively boost immune response, and significantly increase the proportions of CD4+ T cells, CD8+ T cells as well as the decreased Tregs proportion, demonstrating an remarkable immunotherapy efficacy on cancer ablation.